Notebook

Martin Marietta Boosts Royalty Split SSC Magnets Attract Criticism PBS Series Looks At Astronomers Chips In The Edifice Of Science NSF Cleans Up Its Antarctic Act Scientists at Oak Ridge National Laboratory and four other DOE facilities operated by Martin Marietta Energy Systems in Tennessee, Ohio, and Kentucky will get higher royalties under a new policy adopted by the government contractor. Martin Marietta will now give inventors of licensed technology 15 percent of gross royalty recei

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientists at Oak Ridge National Laboratory and four other DOE facilities operated by Martin Marietta Energy Systems in Tennessee, Ohio, and Kentucky will get higher royalties under a new policy adopted by the government contractor. Martin Marietta will now give inventors of licensed technology 15 percent of gross royalty receipts, up from 10 percent under the old policy, and those who invented or supported unlicensed technology will get 5 percent of gross royalties from all licenses, up from the current 4 percent. The new policy also removes a $100,000 cap per license. Nearly 100 employees have received a total of $200,000 since the program was begun in 1984, says William Carpenter, the company's vice president for technology transfer, and Martin Marietta has received $1.3 million in royalties on some 49 licenses. "Nobody's reached the limit [on potential royalty earnings]," says Carpenter, "but it's nice to know that we've helped ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies